{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-029094","form_type":"8-K","ticker":"CHRN","cik":"0001549084","company_name":"EKSO BIONICS HOLDINGS, INC.","filed_at":"2023-10-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.476234+00:00","generated_at":"2026-06-09T08:31:37.405430+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Ekso Bionics Q3 revenue up 38% to $4.6M; net loss narrows to $0.24/share","bullets":["Revenue of $4.6M, up 38% YoY; gross margin improved to 53% from 51%.","Net loss narrowed to $3.4M ($0.24 per share) from $4.3M ($0.33) in Q3 2022.","Sold 41 EksoHealth devices, including a record quarter of EVO unit sales.","Cash on hand $9.9M at Sep 30, 2023, down from $20.5M at Dec 31, 2022.","Company applied for CMS code determination for Indego Personal exoskeleton."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-029094","json":"https://secwatch.observer/filing/0001437749-23-029094.json","markdown":"https://secwatch.observer/filing/0001437749-23-029094.md","text":"https://secwatch.observer/filing/0001437749-23-029094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549084/000143774923029094/0001437749-23-029094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549084/000143774923029094/ekso20231024c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T08:31:37.405430+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"23fe6b3ebb575b7f61d56b305ff72adc7dbaa8aa","claim":"EKSO BIONICS HOLDINGS, INC. reported financial results for the three and nine months ended September 30, 2023.","evidence_excerpt":"On October 26, 2023 Ekso Bionics Holdings, Inc. (the “Company”) reported its financial results for the three and nine months ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549084/000143774923029094/0001437749-23-029094-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and nine months ended September 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}